Maze Therapeutics reported cash from operations of -$15.05M and free cash flow of -$15.16M for the quarter ended Jun 2026, up 49.9% year over year. This cash flow statement covers 10 quarters of results from Mar 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | -27.73M | 139.06M | -24.73M | -39.62M | -32.79M | -33.68M | -30.09M | -7.03M | -24.21M | -44.73M |
| Share-based Compensation | 2.31M | 2.14M | 2.34M | 2.85M | 5.28M | 5.35M | 5.75M | 6.07M | 7.11M | 9.19M |
| Cash from Operations | -23.44M | 145.05M | -23.20M | -22.45M | -29.52M | -30.05M | -24.64M | -27.73M | -39.11M | -15.05M |
| Depreciation, Depletion & Amortization | ||||||||||
| Amortizatization of Intangibles | 0.23M | 0.00M | -0.01M | |||||||
| Amortization of Deferred Charges | 0.37M | 0.13M | ||||||||
| Change in Working Capital | ||||||||||
| Change in Receivables | 20.00M | |||||||||
| Change in Account Payables | -0.24M | 0.39M | -1.17M | 0.82M | 0.58M | 1.27M | -0.75M | -1.12M | 2.21M | -1.79M |
| Change in Accured Expenses | -0.13M | 3.80M | -1.70M | 1.84M | -1.06M | 0.11M | 2.48M | 1.96M | -4.07M | 3.98M |
| Other Working Capital Changes | -1.11M | -0.30M | -0.72M | -0.78M | -0.81M | 2.56M | 0.76M | -5.83M | -0.92M | -0.93M |
| Investing Activities | ||||||||||
| Capital Expenditures | 0.28M | 0.16M | 0.10M | 0.60M | 0.30M | 0.39M | 0.07M | 0.03M | 0.09M | 0.11M |
| Change in Acquisitions & Divestments | 30.00M | 34.00M | ||||||||
| Cash from Investing Activities | -0.28M | -0.16M | -0.10M | -0.60M | -0.30M | -0.39M | -66.88M | -103.39M | 6.28M | -128.51M |
| Financing Activities | ||||||||||
| Other financing activities | 0.36M | 0.08M | 0.23M | 0.06M | 127.75M | 2.45M | 11.55M | -0.48M | 4.08M | 1.70M |
| Debt Issuance and Repayment | ||||||||||
| Long-Term Debt Issuances | 39.40M | |||||||||
| Change in Capital Stock | ||||||||||
| Net Shares Issued and Repurchased | 1.06M | |||||||||
| Misc. | ||||||||||
| Cash from Financing Activities | 24.58M | 0.15M | -2.15M | 70.26M | 127.38M | 0.61M | 143.76M | 3.59M | 42.36M | 147.44M |
| Change in Cash | 0.86M | 145.04M | -25.46M | 47.20M | 97.56M | -29.83M | 52.23M | -127.53M | 9.52M | 3.88M |
| Free Cash Flow | -23.72M | 144.89M | -23.31M | -23.06M | -29.82M | -30.45M | -24.71M | -27.76M | -39.21M | -15.16M |
| Net Cash Flow | 0.86M | 145.04M | -25.46M | 47.20M | 97.56M | -29.83M | 52.23M | -127.53M | 9.52M | 3.88M |